CS216927B2 - Method of making the new aminothiazole derivatives - Google Patents

Method of making the new aminothiazole derivatives Download PDF

Info

Publication number
CS216927B2
CS216927B2 CS793728A CS372879A CS216927B2 CS 216927 B2 CS216927 B2 CS 216927B2 CS 793728 A CS793728 A CS 793728A CS 372879 A CS372879 A CS 372879A CS 216927 B2 CS216927 B2 CS 216927B2
Authority
CS
Czechoslovakia
Prior art keywords
phenyl
carbon atoms
hydrogen
mol
compounds
Prior art date
Application number
CS793728A
Other languages
Czech (cs)
English (en)
Inventor
Joseph G Lombardino
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of CS216927B2 publication Critical patent/CS216927B2/cs

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/52—Radicals substituted by nitrogen atoms not forming part of a nitro radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38—Nitrogen atoms
    • C07D277/42—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/14—Radicals substituted by singly bound hetero atoms other than halogen
    • C07D333/20—Radicals substituted by singly bound hetero atoms other than halogen by nitrogen atoms
    • F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
    • F16—ENGINEERING ELEMENTS AND UNITS; GENERAL MEASURES FOR PRODUCING AND MAINTAINING EFFECTIVE FUNCTIONING OF MACHINES OR INSTALLATIONS; THERMAL INSULATION IN GENERAL
    • F16B—DEVICES FOR FASTENING OR SECURING CONSTRUCTIONAL ELEMENTS OR MACHINE PARTS TOGETHER, e.g. NAILS, BOLTS, CIRCLIPS, CLAMPS, CLIPS OR WEDGES; JOINTS OR JOINTING
    • F16B15/00—Nails; Staples
    • F16B15/0023—Nail plates
    • F16B2015/0076—Nail plates with provisions for additional fastening means, e.g. hooks, holes for separate screws or nails, adhesive

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
CS793728A 1978-06-02 1979-05-30 Method of making the new aminothiazole derivatives CS216927B2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US91183078A 1978-06-02 1978-06-02

Publications (1)

Publication Number Publication Date
CS216927B2 true CS216927B2 (en) 1982-12-31

Family

ID=25430923

Family Applications (1)

Application Number Title Priority Date Filing Date
CS793728A CS216927B2 (en) 1978-06-02 1979-05-30 Method of making the new aminothiazole derivatives

Country Status (36)

Country Link
JP (1) JPS5936988B2 (fr)
AR (1) AR226285A1 (fr)
AT (1) AT373248B (fr)
AU (1) AU511242B2 (fr)
BE (1) BE876732A (fr)
CA (1) CA1117949A (fr)
CH (1) CH639653A5 (fr)
CS (1) CS216927B2 (fr)
DD (1) DD144055A5 (fr)
DE (1) DE2922523C2 (fr)
DK (1) DK150068C (fr)
EG (1) EG14354A (fr)
ES (1) ES481220A1 (fr)
FI (1) FI68820C (fr)
FR (1) FR2427333A1 (fr)
GB (1) GB2022085B (fr)
GR (1) GR73142B (fr)
HK (1) HK66487A (fr)
HU (1) HU180045B (fr)
IE (1) IE48426B1 (fr)
IL (1) IL57450A (fr)
IT (1) IT1121238B (fr)
KE (1) KE3459A (fr)
LU (1) LU81349A1 (fr)
MY (1) MY8500318A (fr)
NL (1) NL178421C (fr)
NO (1) NO150760C (fr)
NZ (1) NZ190623A (fr)
PH (1) PH17020A (fr)
PL (1) PL117515B1 (fr)
PT (1) PT69718A (fr)
SE (1) SE438333B (fr)
SG (1) SG56184G (fr)
SU (1) SU843746A3 (fr)
YU (1) YU40997B (fr)
ZA (1) ZA792729B (fr)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1982001481A1 (fr) * 1980-10-24 1982-05-13 Ronald P Hansen Systeme de reduction de la poussiere
DE3264595D1 (en) * 1981-01-08 1985-08-14 Mitsui Toatsu Chemicals N-(4-phenyl-2-thiazolyl)carbamate derivatives, process for their preparation, and medicinal composition containing same
JPS57136579A (en) * 1981-01-21 1982-08-23 Mitsui Toatsu Chem Inc Thiazolylurea derivative, its preparation, and pharmaceutical composition containing the same
JPS57116067A (en) * 1981-01-12 1982-07-19 Sankyo Kagaku Kk Novel 8-quinolinesulfonyl derivative, its synthesis and use
WO1982002386A1 (fr) * 1981-01-13 1982-07-22 Sakano Isao Derives d'aminothiazoles, procede de preparation et composition medicinale les contenant
EP0069154B1 (fr) * 1981-01-13 1986-10-15 Mitsui Toatsu Kagaku Kabushiki Kaisha Nouveaux composes de thiazole, procede de preparation, et composition medicinale en contenant
JPS57154175A (en) * 1981-03-16 1982-09-22 Mitsui Toatsu Chem Inc 2-thiazoleamine derivative, its preparation, and drug composition comprising it
DE3227329A1 (de) * 1982-07-22 1984-01-26 Basf Ag, 6700 Ludwigshafen Verfahren zur herstellung von 2-n,n-disubstituierten aminothiazolen
WO1986003203A1 (fr) * 1984-11-22 1986-06-05 Yoshitomi Pharmaceutical Industries, Ltd. Derives de thienylthiazole
FR2581063B1 (fr) * 1985-04-30 1987-07-17 Chauvin Blache Lab Amino-2 thiazoles n-substitues, leur procede de preparation et leur application en therapeutique
JPS63152368A (ja) * 1986-06-03 1988-06-24 Sumitomo Pharmaceut Co Ltd 新規なアミノアゾ−ル誘導体およびその酸付加塩
JPH075579B2 (ja) * 1986-09-01 1995-01-25 吉富製薬株式会社 アミノチアゾ−ル化合物
JPH0753666B2 (ja) * 1987-09-14 1995-06-07 久光製薬株式会社 置換ジフェニルチアゾール誘導体からなる抗炎症剤
US5463524A (en) * 1989-08-10 1995-10-31 Commonwealth Scientific And Industrial Research Organisation Producing electrosuspensions
EP0592664B1 (fr) * 1991-03-07 2000-07-05 Hisamitsu Pharmaceutical Co., Inc. Derives de diphenylthiazole ayant une activite antiinflammatoire
FR2692893B1 (fr) * 1992-06-24 1994-09-02 Sanofi Elf Dérivés alkylamino ramifiés du thiazole, leurs procédés de préparation et les compositions pharmaceutiques qui les contiennent.
JPH10504542A (ja) * 1994-07-27 1998-05-06 ジー．ディー．サール アンド カンパニー 炎症処置用の置換チアゾール化合物
FR2754258B1 (fr) 1996-10-08 1998-12-31 Sanofi Sa Derives d'aminothiazole, leur procede de preparation et les compositions pharmaceutiques les contenant
JP2003525291A (ja) * 2000-03-01 2003-08-26 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ ２，４−二置換チアゾリル誘導体
EP1423113A4 (fr) * 2001-08-13 2007-04-18 Phenex Pharmaceuticals Ag Composes de liaison au recepteur nucleaire nr1h4
WO2003027101A1 (fr) * 2001-09-26 2003-04-03 Bayer Pharmaceuticals Corporation 3-pyridyl pyrroles et 3-pyridyl pyrazoles substitues en tant qu'inhibiteurs de la lyase c17,20
DE60328161D1 (de) 2002-01-11 2009-08-13 Daiichi Sankyo Co Ltd Aminoalkoholderivat oder phosphonsäurederivat und diese enthaltende medizinische zusammensetzung
EP1555264A1 (fr) * 2004-01-15 2005-07-20 Sireen AG Hétérocycles à cinq chaínons comme inhibiteurs de la famille des SRC proteines kinases
WO2005079788A1 (fr) 2004-02-24 2005-09-01 Sankyo Company, Limited Composé d’alcool aminé
KR20080019213A (ko) 2005-05-09 2008-03-03 아칠리온 파르마세우티칼스 인코포레이티드 티아졸 화합물 및 그 사용방법
EP1981884B1 (fr) 2006-01-18 2012-06-13 Amgen, Inc Composés thiazoliques comme inhibiteurs de protéine kinase b
WO2009011880A2 (fr) 2007-07-17 2009-01-22 Amgen Inc. Modulateurs hétérocycliques de pkb
WO2009011871A2 (fr) 2007-07-17 2009-01-22 Amgen Inc. Thiadiazoles modulateurs de l'activité de pkb
WO2012170951A2 (fr) * 2011-06-10 2012-12-13 Calcimedica, Inc. Composés modulant le calcium intracellulaire
WO2012170931A2 (fr) 2011-06-10 2012-12-13 Calcimedica, Inc. Composés qui modulent le calcium intracellulaire
WO2013059677A1 (fr) 2011-10-19 2013-04-25 Calcimedica, Inc. Composés qui modulent le calcium intracellulaire
CN110590785B (zh) * 2019-09-23 2021-02-02 武汉大学 一种氨基噻唑类化合物及其制备方法与抗肠道病毒71型的应用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3458526A (en) * 1966-09-26 1969-07-29 Upjohn Co Certain 2-amino-4,5-bis(p-methoxyphenyl)thiazoles

Also Published As

Publication number Publication date
DK177679A (da) 1979-12-03
YU128879A (en) 1982-10-31
ES481220A1 (es) 1980-09-01
GB2022085B (en) 1983-01-12
NZ190623A (en) 1984-07-06
JPS54160369A (en) 1979-12-19
NO150760C (no) 1984-12-12
FI791754A7 (fi) 1979-11-26
CH639653A5 (fr) 1983-11-30
SG56184G (en) 1985-03-08
AU4763479A (en) 1979-12-06
IL57450A0 (en) 1979-09-30
NL7904337A (nl) 1979-12-04
BE876732A (fr) 1979-12-03
SE7904798L (sv) 1979-12-03
EG14354A (en) 1984-06-30
AU511242B2 (en) 1980-08-07
PL117515B1 (en) 1981-08-31
PT69718A (en) 1979-07-01
FI68820B (fi) 1985-07-31
LU81349A1 (fr) 1979-12-07
JPS5936988B2 (ja) 1984-09-06
GR73142B (fr) 1984-02-09
IE791069L (en) 1979-12-02
SE438333B (sv) 1985-04-15
IE48426B1 (en) 1985-01-23
NO791831L (no) 1979-12-04
KE3459A (en) 1984-10-12
NL178421C (nl) 1986-03-17
PH17020A (en) 1984-05-11
NL178421B (nl) 1985-10-16
DK150068C (da) 1987-06-29
IT1121238B (it) 1986-03-26
NO150760B (no) 1984-09-03
AR226285A1 (es) 1982-06-30
PL216030A1 (fr) 1980-03-10
HU180045B (en) 1983-01-28
IT7923228A0 (it) 1979-06-01
DD144055A5 (de) 1980-09-24
ATA401679A (de) 1983-05-15
YU40997B (en) 1986-10-31
FR2427333A1 (fr) 1979-12-28
IL57450A (en) 1982-11-30
DE2922523C2 (de) 1982-10-21
FI68820C (fi) 1985-11-11
FR2427333B1 (fr) 1983-05-20
MY8500318A (en) 1985-12-31
HK66487A (en) 1987-09-25
ZA792729B (en) 1981-03-25
DK150068B (da) 1986-12-01
SU843746A3 (ru) 1981-06-30
CA1117949A (fr) 1982-02-09
GB2022085A (en) 1979-12-12
DE2922523A1 (de) 1979-12-06
AT373248B (de) 1983-12-27

Similar Documents

Publication Publication Date Title
CS216927B2 (en) Method of making the new aminothiazole derivatives
US4390701A (en) 1-Amino-2-[3-(3-piperidinomethylphenoxy)propylamino]cyclobutene-3,4-dione
EP0161841B1 (fr) 2-(Guanidino-N-substitué)-4-hétéroarylthiazoles comme agents anti-ulcères
NO170883B (no) Fremgangsmaate for fremstilling av 2-amino-5-hydroksy-4-metylpyrimidin-derivater
JPS6320231B2 (fr)
HU182461B (en) Process for producing new h-2 down-receptore antagonistic thiazole derivatives
US4217355A (en) Amide therapeutic agents
US3632587A (en) Piperazino methyl isatinylidine 3 acetates
US4522943A (en) Chemical compounds
US4307106A (en) Aminothiazoles
JPH0641465B2 (ja) ベンゾチアジンジオキシド誘導体
US4526973A (en) Chemical compounds
US4395553A (en) Chemical compounds
EP0099122A2 (fr) Compositions à base de pepstatine et d'un antagoniste des récepteurs d'histamine H2 ayant une activité anti-ulcére augmentée
HU182645B (en) Process for preparing n-cyano-n'-2-//4-methyl-5-imidazolyl/-methyl-thio/-ethyl-n''-alkinyl-guanidine
US4503051A (en) Substituted 3-cyclobutene-1,2-diones, pharmaceutical compositions thereof and methods of use
US4539316A (en) Pyridine derivatives of 1,2-diaminocyclobutene-3,4-diones
HU176328B (en) Process for preparing isothiocarbamide derivatives
KR820000848B1 (ko) 아미노 티아졸류의 제조방법
US4546188A (en) Substituted 1,2-diaminocyclobutene-3,4-diones
JPS6410512B2 (fr)
US3539585A (en) 4-hydroxy-2-thiazoline-5-alkanoic acids
US4607105A (en) 3-cyclobutene-1,2-dione intermediates
US4772704A (en) 2,5-disubstituted-4(3H)-pyrimidones having histamine H2 -receptor antagonist activity
JPH0450305B2 (fr)